BIOVENUM MONO powder injection 50 ml IMMUNOGLOBULINUM Биовен

BIOVENUM MONO Indications

Substitution therapy

Syndromes primary immunodeficiency, such as:

- Congenital ahamahlobulinemiya and hipohammahlobulinemiya;

- Common variable immunodeficiency;

- Severe combined immunodeficiency;

- Wiskott-Aldrich syndrome;

- Transient hipohammahlobulinemiya children.

 Syndromes secondary imunodyfitsytu such as:

- Severe recurrent bacterial infections in children with HIV / AIDS;

- Cytopenia different genesis (acute and chronic leukemia, aplastic anemia, a condition after cytotoxic therapy);

- Severe bacterial-toxic and viral infections in adults and children (including surgical complications involving bacteremia and septykopiyemichnymy states and in preparing surgical patients before surgery);

- Prevention and treatment of infections in preterm infants with low birth weight.

Immunomodulatory therapy:

- Idiopathic thrombocytopenic purpura;

- Guillain-Barre syndrome;

- Kawasaki disease;

- Chronic inflammatory neuropathy (which demiyelinizuye);

- General myopathy;

- Wegener's granulomatosis;

- Dermatomyositis;

- Systemic connective tissue diseases (rheumatoid arthritis).

Features of the application

Precautions of administration

Some serious side effects may be related to the rate of infusion. It should strictly adhere to the recommended infusion rate. It is necessary to carefully monitor the patient's condition and carefully monitor the appearance of any symptoms throughout the infusion period.